Lyell Immunopharma OverviewLyell Immunopharma Net Income
Profitability analysis for LYEL.
Quarterly Net Income
-$24.15M
↑ 53.73% YoY
As of Mar 2026
Annual Net Income (TTM)
-$246.41M
↑ 26.34% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...